Intelligent Bio Solutions Inc. announced it has been granted its sixth active patent in the United States, U.S. Patent No: 12259385. This patent relates to the proprietary lateral flow test strip inside the company’s Intelligent Fingerprinting Drug Screening Cartridge.
The patent is fundamental to INBS’s testing system, which uses lateral flow technology to detect drugs in fingerprint sweat. This latest grant strengthens the company’s U.S. intellectual property portfolio, which also includes patents covering its Sample Collection Cartridge, cartridge housing, and buffer clip design.
President and CEO Harry Simeonidis stated that securing broad intellectual property protection strengthens the company's competitive position as it plans for entry into the multi-billion dollar U.S. market in 2025. This patent validates the innovative technology and provides protection for current and future screening cartridge products.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.